Published in Eur Neurol on January 01, 1977
Controversies about the treatment of myasthenia gravis. J Neurol Neurosurg Psychiatry (1980) 1.30
Clinical pharmacology of pyridostigmine and neostigmine in patients with myasthenia gravis. J Neurol Neurosurg Psychiatry (1983) 0.81
Pyridostigmine in human breast milk. Br J Clin Pharmacol (1982) 0.75
Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci U S A (1994) 6.72
A PCR artifact: generation of heteroduplexes. Am J Hum Genet (1989) 3.30
Primate eta-globin DNA sequences and man's place among the great apes. Nature (1986) 2.27
Large multi-chromosomal duplications encompass many members of the olfactory receptor gene family in the human genome. Hum Mol Genet (1998) 2.25
Prechewing of food by adults and streptococcal pharyngitis in infants. J Pediatr (1992) 2.10
Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C. Qual Life Res (2000) 2.04
A new colonial type of N. gonorrhoeae. Br J Vener Dis (1975) 1.66
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Measurement of the forward-backward charge asymmetry in top-quark pair production. Phys Rev Lett (2008) 1.53
Differences between the biliary excretion of tri [14C] methyl-(3-hydroxy-phenyl) ammonium iodide in Wistar and Gunn rats. Biochem J (1970) 1.52
A new, simple and accurate method for determining ejection fraction by Doppler echocardiography. Can J Cardiol (1995) 1.52
A case of tetramine poisoning: a lethal rodenticide. Hong Kong Med J (2005) 1.49
ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression. Int J Cancer (2001) 1.46
A simple method for the preparation of gallium chloride from the citrate solution. Eur J Nucl Med (1991) 1.43
Depressive symptoms decline among persons on HIV protease inhibitors. J Acquir Immune Defic Syndr (2000) 1.42
A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med (1997) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
What are the barriers faced by general practitioners in treating depression and anxiety in Hong Kong? Int J Clin Pract (2006) 1.41
Cultivation of type 1 N. Gonorrhoeae in liquid media. Br J Vener Dis (1975) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
hMAF, a small human transcription factor that heterodimerizes specifically with Nrf1 and Nrf2. J Biol Chem (1997) 1.31
Increasing incidence of HIV infections among young gay and bisexual men in Vancouver. AIDS (2001) 1.30
The role of helper lipids in cationic liposome-mediated gene transfer. Biophys J (1996) 1.30
A quantitative gas-liquid chromatographic method for the determination of neostigmine and pyridostigmine in human plasma. J Chromatogr (1976) 1.29
Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohort. HIV Med (2010) 1.29
Neuropathologically distinct prion strains give rise to similar temporal profiles of behavioral deficits. Neurobiol Dis (2005) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
The influence of age on aerosol deposition in children with cystic fibrosis. Eur Respir J (1994) 1.25
Sex trade involvement and rates of human immunodeficiency virus positivity among young gay and bisexual men. Int J Epidemiol (2001) 1.25
Constitutive expression of ErbB-2 in gallbladder epithelium results in development of adenocarcinoma. Cancer Res (2001) 1.25
Total UK multi-centre experience with a novel arterial occlusion device (Duct Occlud pfm). Heart (1996) 1.22
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Cathepsin k is a critical protease in synovial fibroblast-mediated collagen degradation. Am J Pathol (2001) 1.18
Naphthalene-induced respiratory tract toxicity: metabolic mechanisms of toxicity. Drug Metab Rev (2002) 1.18
A retrospective study of endodontically treated mandibular first molars in a Chinese population. J Endod (1993) 1.18
Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol (1990) 1.17
Low-dose metronomic chemotherapy: a systematic literature analysis. Eur J Cancer (2013) 1.16
The removal of 14 C-edrophonium from the circulation. Br J Pharmacol (1972) 1.16
Compliance with oral drug therapy in patients with hematologic malignancy. J Clin Oncol (1987) 1.16
Quantitative gas-liquid chromatographic method for the determination of indomethacin in biological fluids. J Chromatogr (1978) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
An international comparison of childhood injuries in Hong Kong. Inj Prev (2000) 1.13
Buccal morphine--a new route for analgesia? Lancet (1985) 1.11
Effects of basic fibroblast growth factor (bFGF) on early stages of tendon healing: a rat patellar tendon model. Acta Orthop Scand (2000) 1.11
Excretion of 14 C-edrophonium and its metabolites in bile: role of the liver cell and the peribiliary vascular plexus. Br J Pharmacol (1972) 1.11
HIV protease and reverse transcriptase variation and therapy outcome in antiretroviral-naive individuals from a large North American cohort. AIDS (2001) 1.10
Rapamycin: distribution, pharmacokinetics, and therapeutic range investigations. Ther Drug Monit (1995) 1.10
Reducing discriminatory attitudes toward people living with HIV/AIDS (PLWHA) in Hong Kong: an intervention study using an integrated knowledge-based PLWHA participation and cognitive approach. AIDS Care (2005) 1.09
In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents. Antimicrob Agents Chemother (1989) 1.08
Inadequacies in antiretroviral therapy use among Aboriginal and other Canadian populations. AIDS Care (2006) 1.07
Chromosomal localization of the human NF-E2 family of bZIP transcription factors by fluorescence in situ hybridization. Hum Genet (1995) 1.07
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Factors influencing the excretion and relative physiological availability of pethidine in man. J Pharm Pharmacol (1975) 1.07
Effect of tai chi exercise on proprioception of ankle and knee joints in old people. Br J Sports Med (2004) 1.06
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Cloning, analysis, and bacterial expression of human farnesyl pyrophosphate synthetase and its regulation in Hep G2 cells. Biochemistry (1989) 1.04
Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping. J Clin Virol (2007) 1.04
Search for large extra dimensions via single photon plus missing energy final states at sqrt s = 1.96 TeV. Phys Rev Lett (2008) 1.04
Drug-induced malabsorption. Xenobiotica (1973) 1.04
Plasma concentration of edrophonium in man. Clin Pharmacol Ther (1976) 1.03
The two candidate testis-determining Y genes (Zfy-1 and Zfy-2) are differentially expressed in fetal and adult mouse tissues. Genes Dev (1990) 1.03
High performance DNA sequencing, and the detection of mutations and polymorphisms, on the Clipper sequencer. Electrophoresis (1999) 1.02
Simultaneous determination of bufadienolides in the traditional Chinese medicine preparation, liu-shen-wan, by liquid chromatography. J Pharm Pharmacol (1992) 1.02
Rapid high performance liquid chromatographic assay of cephalosporins in biological fluids. J Antimicrob Chemother (1986) 1.02
The pharmacokinetics of (14C)-edrophonium in normal wistar rats and homozygous Gunn rats with ligated renal pedicles. Br J Pharmacol (1974) 1.02
A comparison of the physico-chemical properties and potency of pethidine and phenoperidine [proceedings]. Br J Clin Pharmacol (1980) 1.01
A new technique for performing Syed-Neblett template interstitial implants for gynecologic malignancies using transrectal-ultrasound guidance. Int J Radiat Oncol Biol Phys (1997) 1.01
Efficient conversion of normal prion protein (PrP) by abnormal hamster PrP is determined by homology at amino acid residue 155. J Virol (2001) 1.00
Plasma clearance of neostigmine and pyridostigmine in rats with ligated renal pedicles. Eur J Pharmacol (1973) 1.00
In vitro protein binding characteristics of isoniazid, rifampicin, and pyrazinamide to whole plasma, albumin, and alpha-1-acid glycoprotein. Clin Biochem (1996) 1.00
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
Sputum elastase in steady-state bronchiectasis. Chest (2000) 0.99
Scale-up of adhesive transdermal drug delivery systems. Pharm Res (1997) 0.98
Deletion of beta-strand and alpha-helix secondary structure in normal prion protein inhibits formation of its protease-resistant isoform. J Virol (2001) 0.98
Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer. Hugo J (2010) 0.98
Histochemical characteristics and contractile properties of the spinotrapezius muscle in the rat and the mouse. J Anat (1977) 0.97
Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort. AIDS Care (2005) 0.97
The biliary excretion of trimethyl-14C(3-hydroxyphenyl)ammonium iodide and its metabolic products. Eur J Pharmacol (1970) 0.97
Internal mammary artery to coronary artery bypass in paediatric cardiac surgery. Eur J Cardiothorac Surg (1998) 0.97
Plasma concentration and metabolism of phenoperidine in man. Br J Anaesth (1980) 0.96
BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J Pharmacol Exp Ther (1995) 0.96
Quantitative gas-liquid chromatographic method for the determination of phenoperidine in human plasma. J Chromatogr (1981) 0.96
Plasma clearance of neostigmine and pyridostigmine in the dog. Br J Pharmacol (1978) 0.96
Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis. Clin Cancer Res (2000) 0.95
Pharmacokinetics of flumazenil and midazolam. Br J Anaesth (1993) 0.95
Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development. Oncogene (2000) 0.95
Health related quality of life among persons with HIV after the use of protease inhibitors. Qual Life Res (2000) 0.94
Search for flavor-changing-neutral-current d meson decays. Phys Rev Lett (2008) 0.94
Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies. Am J Transplant (2012) 0.94
Plasma pyridostigmine levels in patients with myasthenia gravis. Clin Pharmacol Ther (1977) 0.93